Dear All: In my inbox this morning is a posting from WHO of a part-time consultancy running from 15 Oct 2018 to 14 Oct 2019 to assist with TPPs for AMR products. The description is: The purpose of the consultancy is to assist the WHO Innovation Access and Use (IAU) Unit in the development of target product

Dear All, As you know, WHO has been driving a series of clinical and preclinical pipeline reviews (go here for my current master list of pipeline reviews, including links to the 2017 and 2019 WHO reviews). In support of the next iteration of this review process, WHO have now posted (go here) a Geneva-based consultancy

Dear All, A fascinating job posting has gone up from WHO and the full text is just below my signature. You have to work your way through the acronyms, but here’s the essence: Last summer, WHO created the Antimicrobial Resistance Multi-Partner Trust Fund (AMR-MPTF). Go here for the announcement. The Trust Fund is a 5-year project

Dear All, WHO has just posted a job opening for a consultant in Geneva to help with spreading the word about AMR by (i) revamping the World Antibiotic Awareness Week (WAAW) campaigns and (ii) facilitating mainstreaming of antimicrobial resistance messages into major global events and scientific conferences. Full details from the posting are below my

Dear All, Two fascinating job opportunities have appeared. Even if you’re not looking for a job, the job descriptions tell you a lot about things going on below the surface: A role at the Associate or Full Professor level in Singapore The National University of Singapore is looking to appoint a Director for an innovative